COVID-19 vaccination in Canada
Information on COVID-19 doses administered and vaccination coverage.
Vaccination coverage
COVID-19 vaccination coverage data across Canada by key demographics and vaccine product. We update this information every Friday at 12:00 PM Eastern Time with data up to and including the previous Saturday.
This report was last updated on with data up to and including MMM DD, YYYY.
On this page
Key updates
Total population
()
12 years and older
()
5 to 11 years New
()
Total population
()
12 years and older
()
5 to 11 years New
()
About COVID-19 vaccines and vaccination
Vaccination programs, primary series and booster doses
Vaccination programs
- COVID-19 vaccination began in Canada on December 14, 2020.
- 5 COVID-19 vaccines are currently approved for use in Canada.
- The COVISHIELD version of the AstraZeneca vaccine is no longer used in Canada as the interim order for its use expired on September 16, 2021.
- The National Advisory Committee on Immunization’s (NACI) recommendations on the use of COVID-19 vaccines can be found in the latest NACI statements.
- People 5 years and older without contraindications to the vaccine are currently eligible for COVID-19 vaccination.
Primary series
- 2-dose vaccines: Pfizer-BioNTech Comirnaty® (12 and older), Pfizer-BioNTech Comirnaty® (5 to 11 years), Moderna Spikevax® (12 and older), and AstraZeneca Vaxzevria (18 and older)
- People who have received only 1 dose are considered partially vaccinated.
- People who have received both doses are considered fully vaccinated.
- Moderately to severely immunocompromised people who have received an additional dose of an mRNA vaccine are considered fully vaccinated.
- 1-dose vaccine: Janssen (18 and older)
- People who have received only 1 dose are considered fully vaccinated.
- Moderately to severely immunocompromised people who have received an additional dose of an mRNA vaccine are considered fully vaccinated.
Booster doses
NACI recommends a booster dose of an mRNA vaccine at least 6 months after the primary series is completed for members of the following populations.
- A booster should be offered to:
- adults 80 years of age and older
- adults living in long-term care or other congregate settings that provide care for seniors
- A booster may be offered to:
- adults 70 to 79 years of age
- people who received 2 doses of the AstraZeneca Vaxzevria/COVISHIELD vaccine or 1 dose of the Janssen vaccine
- adults in or from First Nations, Inuit, and Métis communities
- adults who are frontline health care workers who have direct in-person contact with patients and who were vaccinated with a very short interval
Local information
For local information on doses administered, please see your province’s or territory’s COVID-19 vaccination website.
National vaccination coverage Access and download the national vaccination coverage data over time in .csv format
Figure 1. of who have received of a COVID-19 vaccine in Canada by jurisdiction, MMM DD, YYYY
Hover over or select a portion of the map to see the cumulative number or percent of people vaccinated in Canada and each jurisdiction over time.
New For local vaccination coverage data, please see your province’s or territory’s COVID-19 vaccination website.
Cumulative number and percent of people who have received a COVID-19 vaccine in Canada by vaccination status and jurisdiction, MMM DD, YYYY
Figure 1: Text description
| Week ending | Jurisdiction | Age group | Cumulative number of people who have received at least 1 dose | Cumulative number of partially vaccinated people | Cumulative number of fully vaccinated people | Cumulative percent of people who have received at least 1 dose | Cumulative percent of partially vaccinated people | Cumulative percent of fully vaccinated people |
|---|
Figure 2. of who have received a COVID-19 vaccine in by vaccination status and report week, MMM DD, YYYY
Hover over or select a portion of the line graph to see the cumulative number or percent of people vaccinated by vaccination status and report week.
Cumulative number and percent of people who have received a COVID-19 vaccine in Canada by vaccination status and jurisdiction, MMM DD, YYYY
Figure 2: Text description
| Week ending | Jurisdiction | Age group | Cumulative number of people who have received at least 1 dose | Cumulative number of partially vaccinated people | Cumulative number of fully vaccinated people | Cumulative percent of people who have received at least 1 dose | Cumulative percent of partially vaccinated people | Cumulative percent of fully vaccinated people |
|---|
Figure 3. Cumulative percent of who have received a COVID-19 vaccine in Canada by vaccination status and province or territory, as of MMM DD, YYYY
Notes
Cumulative number and percent of people who have received of a COVID-19 vaccine in Canada by vaccination status and province or territory, as of MMM DD, YYYY
Figure 3: Text description
| Week ending | Jurisdiction | Age group | Cumulative number of people who have received at least 1 dose | Cumulative number of partially vaccinated people | Cumulative number of fully vaccinated people | Cumulative percent of people who have received at least 1 dose | Cumulative percent of partially vaccinated people | Cumulative percent of fully vaccinated people |
|---|
Vaccination coverage by age, sex, and province or territory
A greater percentage of females than males have received a COVID-19 vaccine. Vaccination coverage is highest in adults aged 70 and older.
Table 1. Cumulative number and percent of people in Canada who have received a COVID-19 vaccine by sex and vaccination status, MMM DD, YYYY
| Sex | At least 1 dose | Partially vaccinated | Fully vaccinated |
|---|---|---|---|
| Females | () | () | () |
| Males | () | () | () |
Table 2. Cumulative number and percent of people in Canada who have received a COVID-19 vaccine by age group and vaccination status, MMM DD, YYYY
| Age group (years) | At least 1 dose | Partially vaccinated | Fully vaccinated |
|---|
Figure 4. of people who have received of a COVID-19 vaccine in by age group and sex, MMM DD, YYYY Access and download the vaccination coverage by age, sex, and province/territory data over time in .csv format
Hover over or select a bar to see the cumulative number or percent of people vaccinated so far.
Figure 4: Text description
Cumulative number and percent of people who have received a COVID-19 vaccine in Canada by vaccination status, age group, sex, and jurisdiction, MMM DD, YYYY
| Jurisdiction | Sex | Age group | Cumulative number of people who have received at least 1 dose | Cumulative number of partially vaccinated people | Cumulative number of fully vaccinated people | Cumulative percent of people who have received at least 1 dose | Cumulative percent of partially vaccinated people | Cumulative percent of fully vaccinated people |
|---|
Figure 5. of who have received of a COVID-19 vaccine in by age group and report week, MMM DD, YYYY Access and download the vaccination coverage by age, sex, and province/territory data over time in .csv format
Hover over or select a portion of the line graph to see the cumulative number or percent of people vaccinated by age group and report week. Click on a legend element to add or remove the corresponding lines from the graph.
Cumulative number and percent of people who have received a COVID-19 vaccine in Canada by vaccination status, age group, sex, and jurisdiction, MMM DD, YYYY
Figure 5: Text description
| Week ending | Jurisdiction | Sex | Age group | Cumulative number of people who have received at least 1 dose | Cumulative number of partially vaccinated people | Cumulative number of fully vaccinated people | Cumulative percent of people who have received at least 1 dose | Cumulative percent of partially vaccinated people | Cumulative percent of fully vaccinated people |
|---|
Coverage by vaccine product Access and download the vaccination coverage by age, sex, and province/territory data in .csv format
5 COVID-19 vaccines approved for use in Canada: Pfizer-BioNTech Comirnaty®, Pfizer-BioNTech Comirnaty® (5 to 11 years), Moderna Spikevax®, AstraZeneca Vaxzevria, and Janssen.
- Among those vaccinated, most have received the Pfizer-BioNTech Comirnaty vaccine.
- Delivery of the Janssen COVID-19 vaccine to provinces and territories began on November 8, 2021. Before this, residents of Canada could only be vaccinated with the Janssen vaccine in other countries.
- The Combination category includes people who received different vaccines for their first and second doses (see definitions).
- The Other category includes people who have been vaccinated with a vaccine not approved by Health Canada (see definitions).
Table 3. Cumulative percent and number of people who have received a COVID-19 vaccine in Canada by vaccine product and vaccination status, MMM DD, YYYY
| COVID-19 vaccine | At least 1 dose | Partially vaccinated | Fully vaccinated |
|---|---|---|---|
| Pfizer-BioNTech Comirnaty | () | () | () |
| Moderna Spikevax | () | () | () |
| COVISHIELD | () | () | () |
| AstraZeneca Vaxzevria | () | () | () |
| Janssen | () | () | () |
| Combination | () | () | () |
| Other | () | () | () |
| Vaccine not reported | () | () | () |
| Vaccine unknown | () | () | () |
Figure 6. of people who have received of a COVID-19 vaccine in by vaccine product and report week, MMM DD, YYYY
Hover over or select a portion of the line graph to see the cumulative number or percent of people vaccinated by vaccine product and report week. Click on a legend element to add or remove the corresponding lines from the graph.
Figure 6: Text description
Cumulative number and percent of people who have received a COVID-19 vaccine by vaccine product, vaccination status, jurisdiction, and report week, MMM DD, YYYY
| Week ending | Jurisdiction | Vaccine | Cumulative number of people who have received at least 1 dose | Cumulative number of partially vaccinated people | Cumulative number of fully vaccinated people | Cumulative percent of people who have received at least 1 dose | Cumulative percent of partially vaccinated people | Cumulative percent of fully vaccinated people |
|---|
Acknowledgements
This weekly report would not be possible without the collaboration of provincial and territorial public health partners as well as members of the Pan-Canadian Public Health Network’s Canadian Immunization Registries and Coverage Network (CIRC). We would like to thank everyone taking part in the COVID-19 vaccination rollout in Canada.
Suggested citation
Public Health Agency of Canada. Canadian COVID-19 vaccination coverage report. Ottawa: Public Health Agency of Canada; January 22, 2021. https://health-infobase.canada.ca/covid-19/vaccination-coverage/
Related links
- Vaccines for COVID-19
- COVID-19: Effectiveness and benefits of vaccination
- COVID-19 Vaccination Coverage Survey (CVCS)
- COVID-19 in Canada
- Vaccine distribution
- Reported side effects following COVID-19 vaccination in Canada
- The facts about COVID-19 vaccines
- Publications: Vaccines and immunization
- Vaccines for children
- Ask the experts video series: COVID-19 vaccines questions
For health professionals
- COVID-19 information for health professionals
- National Advisory Committee on Immunization (NACI)
- COVID-19 daily epidemiology update
Provincial, territorial and other federal COVID-19 vaccination webpages
- British Columbia
- Alberta
- Saskatchewan
- Manitoba
- Ontario
- Quebec
- Newfoundland and Labrador
- New Brunswick
- Nova Scotia
- Prince Edward Island
- Yukon
- Northwest Territories
- Nunavut
- Indigenous Services Canada
- Correctional Service Canada
- Date modified: